NRLN Home Page

Does Medicare Cover GLP-1s
For Weight Loss?
What To Know In 2026

For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from straightforward. There are two distinct pathways: Medicare Part D or the Medicare GLP-1 Bridge Program, based on your specific health condition, plan formulary and other nuances.

This guide breaks down how Medicare Part D handles GLP-1 medications based on diagnosis and eligibility criteria and which pathway to follow, as well as guidance on how to check your policy’s coverage.

What Are GLP-1 Medications?

GLP-1 and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists are approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes, chronic weight management and additional conditions, depending on the individual’s needs.

They work by mimicking gut hormones (GLP-1 or GIP plus GLP-1) to stimulate insulin release, slow digestion and target brain receptors that suppress appetite. Semaglutide is branded as Ozempic (for the treatment of type 2 diabetes) and Wegovy (for the treatment of weight loss), tirzepatide is branded as Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), liraglutide is branded as Victoza (for type 2 diabetes) and Saxenda (for weight loss) and orforglipron is branded as Foundayo (for weight loss).

Medicare Coverage for GLP-1s

Medicare is a federally run program that generally provides health insurance coverage to individuals 65 and over as well as individuals under 65 with certain disabilities or health conditions. Most Medicare Advantage plans (Part C) include prescription drug coverage (Part D). However, if you have Original Medicare (Part A and Part B), you must purchase a separate Part D Plan for medication coverage. GLP-1 and GIP/GLP-1 medications fall under Medicare Part D coverage, although coverage for weight loss follows a different pathway than other FDA-approved uses.

Recent Changes to Medicare Coverage of GLP-1s

Medicare has historically barred coverage from medications prescribed solely for weight loss, says Calvin Bagley, a Medicare advocate and founder of PlanFit, an online Medicare-based platform designed to simplify healthcare plan enrollment. That changed on July 1, 2026, with the launch of the Medicare GLP-1 Bridge program. Running through December 31, 2027, the pilot program allows eligible Part D beneficiaries to access specific GLP-1 medications for weight loss at a $50 monthly copay.

While the Bridge program marks an important shift in access, it is not a blanket expansion of coverage says Whitney Stidom, vice president of consumer enablement at eHealth, an online health insurance marketplace. Instead, Medicare requires beneficiaries to meet strict clinical criteria for approval, including body mass index (BMI) minimums, physician approval and more. ”Understanding those requirements will be just as important as understanding the price,” says Stidom.

“One important detail is that the Bridge program operates separately from the normal Part D formulary process,” adds Bagley. Meaning, consumers must look at different coverage paths for different diagnoses: Coverage is through the Plan D formulary for type 2 diabetes, cardiovascular disease and obstructive sleep apnea, whereas the Medicare Bridge pathway is used for those seeking GLP-1 strictly for weight management. Of note, the copay for GLP-1 medications under the Medicare Bridge Program does not apply toward the beneficiary plan deductible or annual out-of-pocket maximums.

Type 2 Diabetes

Medicare Part D Coverage: GLP-1 medications that are approved for type 2 diabetes are covered, including Ozempic, Mounjaro and Wegovy. However, coverage depends on your plan’s specific drug formulary.

Medicare Eligibility Requirements: Additionally, prior authorization (advance approval for medication coverage), documentation of your diagnosis and evidence of step therapy (attempt and failure controlling the condition with a lower-tier drug, which are less expensive than higher-tier drugs like GLP-1s) may be required.

Weight Loss

Medicare Part D Coverage: Under the Medicare Bridge Program, eligible individuals can access Wegovy (injections and tablets), Zepbound KwikPen (prefilled, multi-dose injector pen) and Foundayo tablets for a $50 copay.

Medicare Part D Eligibility Requirements: Qualification requires prior authorization, evidence of lifestyle modifications including diet and exercise, proof of a BMI over 35 or a BMI over 30 with at least one related health condition, including uncontrolled high blood pressure, diastolic heart failure, chronic kidney disease and prediabetes. Check with your specific plan for information on eligibility criteria for these conditions.

Other Conditions

Medicare Part D Coverage: FDA-approved uses beyond weight loss may be eligible for coverage through Medicare Part D. Wegovy may be prescribed for cardiovascular risk reduction in adults with overweight or obesity and known cardiovascular disease; Zepbound may be prescribed for mild-to-moderate obstructive sleep apnea with obesity.

Medicare Part D Eligibility Requirements: Zepbound for obstructive sleep apnea requires a diagnosis of obesity-related sleep apnea and documentation of formal sleep study results. Qualification for Wegovy requires meeting specific BMI minimums and documentation of cardiovascular disease. Check with your plan administrator for details.

How To Check If Your Medicare Plan Covers GLP-1s

“The most important thing for Medicare beneficiaries to ask is: ‘Is this GLP-1 covered for my diagnosis through my Part D plan, or do I need to qualify through the Medicare GLP-1 Bridge program?’” advises Bagley.

To check your coverage, Bagley recommends following these steps:

1. Confirm that you have Medicare Part D drug coverage.
2. Ask your doctor whether you meet the clinical criteria for the medication’s FDA-approved use.
3. Determine whether the prescription is for weight loss or another diagnosis.
4. If the medication is being prescribed for a medical condition other than weight loss, check your regular plan formulary.
5. Call your Part D plan or Medicare Advantage drug plan to ask how prior authorization is being handled.

Because rules can change rapidly, Bagley recommends confirming coverage with your prescribing doctor, pharmacy benefit manager and insurance provider before assuming a GLP-1 will be covered.

Forbes